Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03060278Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Oklahoma. Primary endpoint: Smoking Status at 3 months. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03060278.